A 62-year-old woman presented to hospital, on general practitioner (GP) advice, with a 15-
day history of slowly progressing muscle weakness. Results showed newly deranged liver …

The withdrawal of cerivastatin from the world market because of deaths from rhabdomyolysis
(a disorder that results from skeletal muscle injury with release of muscle cell contents into …

Drug-induced myopathy and/or rhabdomyolysis have been reported with use of some statins
and fibric acid derivatives. The risk of adverse effects is increased with their concomitant …

Gemfibrozil-statin combination therapy is a well-known risk factor for myopathy and
rhabdomyolysis. Cerivastatin is a currently available statin with dual elimination; it is …

OBJECTIVE: To report a case of severe myopathy associated with concomitant simvastatin
and amiodarone therapy. CASE SUMMARY: A 63-year-old white man with underlying …

Cerivastatin monotherapy-induced muscle weakness, rhabdomyolysis and acute renal failure -
International Journal of Cardiology Skip to Main Content Advertisement International Journal of …

Clinical Rhabdomyolysis With Acute Kidney Injury Secondary to High-Intensity Rosuvastatin
Use: A Case Report - PMC Back to Top Skip to main content NIH NLM Logo Access keys …

Drug-drug interactions in medications metabolized by cytochrome P450 enzymes can lead
to multi-organ complications. An uncommon but serious potential adverse effect of statins is …

3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) are the most widely
prescribed therapeutic class of drugs worldwide, with established clinical benefits both in …

Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) have been shown to
be effective at lowering low-density lipoprotein cholesterol and decreasing the risk of …